高血压
- 标准
- 加费
- 除外(通常不出现)
- 延期
- 拒保
控制良好多为标准;读数偏高或合并其他心血管风险会加费;控制很差先延期。
依据:两份以上公开核保指南一致
在约定年限内身故赔一笔钱,保家人收入与房贷。
核保看「未来多少年内身故风险有多高」:慢病控制、癌症距今年数、心脑血管事件最关键。投保额越高、年龄越大,要的体检越多。
这个险种可能出现的结果
被拒或延期时,可看简化核保(只答问卷)或保证承保(不问健康、保额小、头两年多为退保费)产品。
控制良好多为标准;读数偏高或合并其他心血管风险会加费;控制很差先延期。
依据:两份以上公开核保指南一致
多数会加费;年纪较大、控制好、无并发症时有机会标准;合并心、脑、肾病多拒保。
依据:两份以上公开核保指南一致
通常加费,控制越好、无并发症加得越少;有严重并发症多拒保。个别公司对极好控制可标准。
依据:两份以上公开核保指南一致
三份公开指南都没有单列;一般规律是单独的、控制好的高胆固醇多为标准,主要作为心血管风险的加分项一起看。
依据:一般规律,待核
治疗中与结束后一段时间多为延期;之后按分期加费,年数越久加得越少;原位癌几年后可能标准。
依据:两份以上公开核保指南一致
早期、小的乳头状癌在治疗结束一段时间后常可标准;其他类型或较晚分期等待更久或加费。
依据:两份以上公开核保指南一致
确诊后短期内多延期;早期、治疗多年且 PSA 稳定可标准;其余按年数加费递减。
依据:两份以上公开核保指南一致
手术或事件后一段时间多延期;之后通常加费;发病很年轻或多处病变多拒保。
依据:两份以上公开核保指南一致
发作后一段时间延期或拒保;之后按后遗症与年龄加费;多次发作或严重后遗症多拒保。
依据:两份以上公开核保指南一致
偶发、心脏结构正常可标准;持续性或合并心脏病加费;新近发现或有中风史可能延期或拒保。
依据:两份以上公开核保指南一致
轻中度、控制好多为标准;频繁发作、住院或吸烟加费;极重度可能拒保。
依据:两份以上公开核保指南一致
轻度、已戒烟可能标准或小幅加费;中重度加费;重度或仍吸烟多拒保。
依据:两份以上公开核保指南一致
轻度或坚持治疗多为标准;中重度未治疗加费;合并严重心肺问题可能拒保。
依据:两份以上公开核保指南一致
轻度、稳定多为标准;较重或反复加费;近期住院、自杀行为或正在停工多拒保或延后再议。
依据:两份以上公开核保指南一致
肝功能正常的携带者常为标准或小幅加费;活动性感染延期;有肝硬化多拒保。
依据:两份以上公开核保指南一致
只有一份公开指南单列:单纯脂肪肝、肝功能正常多为标准;肝功能异常或脂肪性肝炎加费;有明显纤维化可能拒保。
依据:只有一份公开核保指南
三份公开指南都没有单列;一般规律是已排出、肾功能正常多为标准。
依据:一般规律,待核
三份公开指南都没有单列;一般规律是确认良性多为标准,检查结果未出时通常延期到出结果。
依据:一般规律,待核
体格表内为标准,超出越多加费越多,极端体重可能拒保;减重手术后通常先延期一段时间再按现体重评估。
依据:只有一份公开核保指南
无并发症多为标准(部分公司要求孕晚期或产后再提交);有并发症通常延期到产后。
依据:只有一份公开核保指南
各公司核保不同,以核保结果为准。本页是一般信息,不是个人医疗或投保建议;病与药的介绍只引官方来源。
先看导读,再看图;点图放大、左右翻页,每张卡都有可分享的详情页。卡上每个字都出自本站正文,不列费率。

价格是个人化的
保费按年龄、性别、是否吸烟和健康状况报价,本站不列费率。持牌保险顾问可在多家公司之间比较报价(可报价的公司以其签约为准),把条款差异列在同一页上。
询价前要准备什么 →Health and insurability atlas / By insurance type
Term life insurance
Pays a lump sum if you die within the term; protects family income and the mortgage.
Underwriting asks how likely death is during the term: control of chronic disease, years since cancer treatment and heart or brain events matter most. Larger amounts and older ages trigger more tests.
Outcomes possible for this type
If declined or postponed, simplified-issue (questions only) or guaranteed-issue (no health questions, small amounts, usually a return of premiums in the first two years) products may be options.
Well controlled is usually standard; higher readings or other cardiac risks lead to a rating; very poor control is postponed.
Basis: Two or more public underwriting guides agree
Most are rated; older applicants with good control and no complications may get standard; with heart, stroke or kidney disease, decline is likely.
Basis: Two or more public underwriting guides agree
Usually rated; better control without complications means a lower rating; serious complications usually lead to decline. A few insurers may offer standard for excellent control.
Basis: Two or more public underwriting guides agree
None of the three public guides lists it separately; generally, controlled high cholesterol alone is standard and is weighed together with other cardiac risks.
Basis: General pattern, to be verified
Usually postponed during and for a while after treatment; then rated by stage, with the rating falling as years pass; in-situ cases may become standard after some years.
Basis: Two or more public underwriting guides agree
Small early papillary cancers can often be standard some time after treatment; other types or later stages wait longer or are rated.
Basis: Two or more public underwriting guides agree
Usually postponed shortly after diagnosis; early-stage cases treated years ago with stable PSA may be standard; others are rated, falling with time.
Basis: Two or more public underwriting guides agree
Usually postponed for a while after a procedure or event, then rated; very young onset or extensive disease is often declined.
Basis: Two or more public underwriting guides agree
Postponed or declined for a period after the event, then rated by residual effects and age; repeated events or major deficits usually decline.
Basis: Two or more public underwriting guides agree
Occasional episodes with a normal heart can be standard; persistent AF or heart disease is rated; newly found or with prior stroke may be postponed or declined.
Basis: Two or more public underwriting guides agree
Mild to moderate controlled asthma is usually standard; frequent attacks, hospital stays or smoking lead to ratings; very severe cases may be declined.
Basis: Two or more public underwriting guides agree
Mild cases who have quit may be standard or lightly rated; moderate to severe are rated; severe or still smoking usually decline.
Basis: Two or more public underwriting guides agree
Mild or well-treated cases are usually standard; untreated moderate to severe cases are rated; with serious heart or lung problems, decline is possible.
Basis: Two or more public underwriting guides agree
Mild, stable cases are usually standard; more severe or recurrent ones are rated; recent hospital stays, suicide attempts or current time off work usually decline or are reconsidered later.
Basis: Two or more public underwriting guides agree
Carriers with normal liver tests are often standard or lightly rated; active infection is postponed; cirrhosis usually declines.
Basis: Two or more public underwriting guides agree
Only one public guide lists it: simple fatty liver with normal tests is usually standard; abnormal tests or steatohepatitis are rated; significant scarring may decline.
Basis: One public underwriting guide only
None of the three public guides lists it; generally, passed stones with normal kidney function are standard.
Basis: General pattern, to be verified
None of the three public guides lists it; generally, confirmed benign nodules are standard, and pending investigations are postponed until results are in.
Basis: General pattern, to be verified
Within the build chart is standard; further above means higher ratings; extreme weight may decline. After weight-loss surgery there is usually a waiting period, then assessment at current weight.
Basis: One public underwriting guide only
Uncomplicated pregnancy is usually standard (some insurers wait until late pregnancy or after delivery); with complications, postponed until after delivery.
Basis: One public underwriting guide only
Underwriting differs by insurer; the insurer’s decision is final. General information only, not personal medical or insurance advice; condition and medication descriptions cite official sources.